Lolli, Graziano
 Distribuzione geografica
Continente #
NA - Nord America 3.679
AS - Asia 1.313
EU - Europa 991
SA - Sud America 205
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 6.226
Nazione #
US - Stati Uniti d'America 3.626
SG - Singapore 644
CN - Cina 257
IT - Italia 256
RU - Federazione Russa 187
VN - Vietnam 184
BR - Brasile 172
SE - Svezia 103
GB - Regno Unito 90
DE - Germania 81
FI - Finlandia 72
FR - Francia 59
LV - Lettonia 49
KR - Corea 44
BD - Bangladesh 33
CA - Canada 32
HK - Hong Kong 27
IN - India 24
ID - Indonesia 19
NL - Olanda 19
AR - Argentina 16
IQ - Iraq 16
TR - Turchia 15
JP - Giappone 14
BG - Bulgaria 13
MX - Messico 13
UA - Ucraina 11
ES - Italia 8
KE - Kenya 8
PL - Polonia 8
AT - Austria 6
JO - Giordania 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
MA - Marocco 5
CL - Cile 4
EC - Ecuador 4
EU - Europa 4
HR - Croazia 4
VE - Venezuela 4
AU - Australia 3
CZ - Repubblica Ceca 3
LT - Lituania 3
MY - Malesia 3
PH - Filippine 3
SN - Senegal 3
AL - Albania 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KH - Cambogia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
IE - Irlanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
TW - Taiwan 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 6.226
Città #
Ashburn 420
Singapore 394
Fairfield 382
Chandler 341
San Jose 201
Woodbridge 168
San Mateo 164
Wilmington 151
Houston 140
Seattle 125
Dallas 118
Santa Clara 117
Cambridge 109
Moscow 90
Columbus 89
Princeton 85
The Dalles 59
Ann Arbor 54
Beijing 54
Los Angeles 53
Trento 50
Helsinki 49
Riga 49
Ho Chi Minh City 45
Seoul 43
Lauterbourg 41
Council Bluffs 40
Hanoi 38
Jacksonville 35
London 30
New York 30
San Diego 28
Como 24
Bremen 21
Buffalo 20
Munich 20
Orem 20
Da Nang 19
Falls Church 17
Hong Kong 17
Jakarta 17
Milan 17
Washington 17
Dearborn 16
Fremont 16
Sofia 13
São Paulo 13
Toronto 13
Chicago 12
Montreal 11
Frankfurt am Main 10
Hefei 10
Rome 10
Shanghai 10
Turku 9
Baghdad 8
Bologna 8
Brooklyn 8
Dong Ket 8
Tokyo 8
Warsaw 8
Hangzhou 7
Nanjing 7
Rio de Janeiro 7
San Paolo di Civitate 7
Amsterdam 6
Bassano del Grappa 6
Denver 6
Guangzhou 6
Haiphong 6
Kilburn 6
Manchester 6
Monfalcone 6
New Delhi 6
Norwalk 6
Redondo Beach 6
Riva Del Garda 6
Salt Lake City 6
San Francisco 6
Trieste 6
Wuhan 6
Boston 5
Brasília 5
Bến Tre 5
Campinas 5
Chennai 5
Elk Grove Village 5
Hillsboro 5
Izmir 5
Nairobi 5
Phoenix 5
Stockholm 5
Altamura 4
Boardman 4
Carapicuíba 4
Kunming 4
Lancaster 4
Mexico City 4
Nuremberg 4
Querétaro 4
Totale 4.403
Nome #
Discovery of Inhibitors of Four Bromodomains by Fragment-Anchored Ligand Docking 290
Pharmacological inactivation of the prion protein by targeting a folding intermediate 244
High-Throughput Fragment Docking into the BAZ2B Bromodomain: Efficient in Silico Screening for X-Ray Crystallography 225
Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin 209
Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains 209
Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery 207
Discovery of BAZ2A bromodomain ligands 197
The "gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains 197
The STAS domain of mammalian SLC26A5 prestin harbours an anion-binding site 189
Structural characterization of the STAS domain of prestin. 174
A novel class of selective CK2 inhibitors targeting its open hinge conformation 171
Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface 170
Derivatives of 3-Amino-2-methylpyridine as BAZ2B Bromodomain Ligands: In Silico Discovery and in Crystallo Validation 167
Flavopiridol binding to P-TEFb (CDK9/cyclin T1) 165
Auto-inhibitory assembly of protein kinase CK2 revealed by X-ray crystallography. 164
Characterization of the oligomeric states of the CK2 α2β2 holoenzyme in solution 164
Structural Basis of CK2 Regulation by Autoinhibitory Oligomerization 161
CAK—Cyclin-Dependent Activating Kinase: A Key Kinase in Cell Cycle Control and a Target for Drugs? 148
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: Structural features and pharmacological potential 147
Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain 137
Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight 133
Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining 133
Pliability in the m6A-Binding Region Extends Druggability of YTH Domains 131
GroEL from the psychrophilic bacterium Pseudoalteromonas haloplanktis TAC 125: molecular characterization and gene cloning 126
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states 122
Small-Molecule Ebselen Binds to YTHDF Proteins Interfering with the Recognition of N 6-Methyladenosine-Modified RNAs 121
Active Form of the Protein Kinase CK2 alpha(2)beta(2) holoenzyme Is a Strong Complex with Symmetric Architecture 120
The Crystal Structure of Human CDK7 and Its Protein Recognition Properties 111
Molecular architecture of the glycogen- committed PP1/PTG holoenzyme 110
Inhibitory Properties of ATP-Competitive Coumestrol and Boldine Are Correlated to Different Modulations of CK2 Flexibility 110
Insight into GFPmut2 pH Dependence by Single Crystal Microspectrophotometry and X-ray Crystallography 109
Binding to DNA of the RNA-polymerase II C-Terminal Domain allows discrimination between Cdk7 ad Cdk9 phosphorylation 106
Reevaluation of bromodomain ligands targeting BAZ2A 90
Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing 90
Inhibitor affinity chromatography: Profiling the specific reactivity of the proteome with immobilized molecules 88
PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability 81
Enhanced cellular death in liver and breast cancer cells by dual BET/BRPF1 inhibitors 76
Structural Determinants of Protein Kinase CK2 Regulation by Autoinhibitory Polymerization 75
Recognition of Cdk2 by Cdk7 73
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer 70
New directions for CDKs and HDACs inhibition in cancer therapy 68
Mapping cryptic phosphorylation sites in the human proteome 63
Structure and single crystal spectroscopy of Green Fluorescent Proteins 63
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation 62
Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2 60
Structural dissection of cyclin dependent kinases regulation and protein recognition properties 59
The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2 54
Structural and functional determinants of protein kinase CK2 alpha: facts and open questions 50
Protein glycosylation and synaptic transmission: brain glycogen keeps them separated 32
Switching off CK2-mediated activation of survivin offers new therapeutic opportunities in neuroblastoma 28
Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient 21
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort 10
Totale 6.380
Categoria #
all - tutte 29.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.049
Totale 30.739


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022678 51 68 3 20 61 28 15 182 37 81 40 92
2022/2023698 94 78 6 106 67 118 1 65 108 16 26 13
2023/2024317 22 33 47 11 32 65 12 19 2 19 8 47
2024/20251.177 18 23 64 222 78 153 38 29 140 256 97 59
2025/20262.172 138 51 222 305 220 193 367 64 180 225 130 77
Totale 6.380